Pharmaceutical Business review

Gilead receives subpoena for HIV drugs

The documents relate to the drugs Truvada, Viread and Emtriva. Truvada is a combination of Viread and Emtriva. Truvada is for use in combination with other anti-HIV agents to treat HIV infection in adults

Recently there have been a number of investigations into the marketing practices of biotechnology companies. Intermune was accused of illegally promoting its lung disease drug but did not challenge the allegations and a division of Johnson & Johnson, Scios has allegedly improperly promoted frequent injections of its heart drug Natrecor in out-patient settings.

Gilead said it intends to comply with the subpoena and to cooperate in any related government investigation.